The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Open accessThe DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Abstract
Gut microbiota is emerging as a key regulator of many disease conditions and its dysregulation is implicated in the pathogenesis of several gastrointestinal and extraintestinal disorders. More recently, gut microbiome alterations have been linked to neurodegeneration through the increasingly defined gut microbiota brain axis, opening the possibility for new microbiota-based therapeutic options. Although several studies have been conducted to unravel the possible relationship between Alzheimer’s Disease (AD) pathogenesis and progression, the diagnostic and therapeutic potential of approaches aiming at restoring gut microbiota eubiosis remain to be fully addressed. In this narrative review, we briefly summarize the role of gut microbiota homeostasis in brain health and disease, and we present evidence for its dysregulation in AD patients. Based on these observations, we then discuss how dysbiosis might be exploited as a new diagnostic tool in early and advanced disease stages, and we examine the potential of prebiotics, probiotics, fecal microbiota transplantation, and diets as complementary therapeutic interventions on disease pathogenesis and progression, thus offering new insights into the diagnosis and treatment of this devastating and progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following the successful use of FMT in the treatment of refractory or recurrent Clostridium difficile infection, several studies have been conducted to explore FMT as a therapeutic strategy for a wide range of neurological disorders, including multiple sclerosis, epilepsy, ASD, Tourette syndrome, diabetic neuropathy, AD and PD, with promising preclinical and clinical data [30,465,466,467,468].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“GM-based biomarkers have recently been considered as promising early and prodromal diagnostic tools in various neurological diseases, such as multiple sclerosis, AD and PD itself [30,156,157]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“• Through incoming and outgoing branches of the vagus nerve [26], which represents the major modulatory pathway [27].”
BackgroundParada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820 · cited 1×
“As mentioned, another beneficial role exerted by the gut microbiota is the production of SCFAs, including butyrate, propionate, and acetate, essential for energy production, gut epithelia homeostasis, and immune regulation [83].”
BackgroundFormation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 1×
“Although the composition of a “healthy microbiota” has not yet been defined, a balanced environment between the host and microorganisms is known to be essential to carry on the necessary immunological and metabolic functions [58].”
BackgroundPathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228 · cited 1×
“This alteration, in turn, may affect the CNS through the modulation of stress hormones [28].”
BackgroundPathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 1×
“The disease is characterized by the progressive deposition of beta amyloid (Aβ) plaques and tangles of hyperphosphorylated tau neurofibrils, leading to neuroinflammation and progressive cognitive decline [2].”
BackgroundThe gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., & Balamurugan, R. (2020) · Nutrients · doi:10.3390/nu12051474 · Cited by 2,335 · cited 1×
“Indeed, although initially hypothesized for gastrointestinal disorders [102], gut microbiomederived biomarkers have also been considered for psychological and neurodegenerative diseases (i.”
BackgroundAltered fecal microbiota composition in patients with major depressive disorder
Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.016 · Cited by 2,275
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137 · cited 1×
“detected a significant dampen in Firmicutes and Bifidobacteria in the fecal samples of AD patients, and this decrease was counterbalanced by the overgrowth of Bacteroidetes species in the same individuals [70].”
Dysbiosis and the immune system
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A., & Elinav, E. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.7 · Cited by 1,769
Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications
Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., Mohkam, M., Masoumi, S., Berenjian, A., & Ghasemi, Y. (2019) · Foods · doi:10.3390/foods8030092 · Cited by 1,716
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382 · cited 2×
“rectale, and that this microbiota alteration is associated with amyloidosis and peripheral inflammation [36].”
BackgroundPrinciples and clinical implications of the brain-gut-enteric microbiota axis
Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.35 · Cited by 1,342
Psychobiotics: A novel class of psychotropic
Dinan, T. G., Stanton, C., & Cryan, J. F. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.001 · Cited by 1,287
Probiotics: Growth-Promoting Factors Produced by Microorganisms
Lilly, D. M., & Stillwell, R. H. (1965) · Science · doi:10.1126/science.147.3659.747 · Cited by 1,243
Probiotic Mechanisms of Action
Bermudez-Brito, M., Plaza-Díaz, J., Muñoz-Quezada, S., Gómez-Llorente, C., & Gil, A. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000342079 · Cited by 1,234
O’Toole, P. W., & Jeffery, I. B. (2015) · Science · doi:10.1126/science.aac8469 · Cited by 1,202
MIND diet associated with reduced incidence of Alzheimer's disease
Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Bennett, D. A., & Aggarwal, N. T. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.009 · Cited by 1,162
The microbiota-gut-brain axis: from motility to mood
Margolis, K. G., Cryan, J. F., & Mayer, E. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.066 · Cited by 999 · cited 2×
“• Through incoming and outgoing branches of the vagus nerve [26], which represents the major modulatory pathway [27].”
BackgroundGhosh, T. S., Rampelli, S., Jeffery, I. B., Santoro, A., Neto, M., Capri, M., Giampieri, E., Jennings, A., Candela, M., Turroni, S., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319654 · Cited by 991
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971 · cited 1×
“Probably, this was due to the antimicrobial activity of Aβ peptide, as the heparin-binding motif of Aβ oligomers make easier the binding to the glycosyl group of the carbohydrate moiety in the bacterial cell wall, so preventing its adhesion to the host cell and the induction of microbial agglutination [37].”
BackgroundMediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial
Valls-Pedret, C., Sala-Vila, A., Serra-Mir, M., Corella, D., de la Torre, R., Martínez-González, M. Á., Martínez-Lapiscina, E. H., Fitó, M., Pérez-Heras, A., Salas-Salvadó, J., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.1668 · Cited by 952
Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00256 · Cited by 946
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Regional variation limits applications of healthy gut microbiome reference ranges and disease models
He, Y., Wu, W., Zheng, H.-M., Li, P., McDonald, D., Sheng, H.-F., Chen, M.-X., Chen, Z.-H., Ji, G.-Y., Zheng, Z.-D.-X., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0164-x · Cited by 894 · cited 1×
“Although reductive, this discrepancy might be at least in part explained by the different geographical origin of the participants, since regional identity may strongly affect gut microbiota composition, as well as other comorbidities [78].”
BackgroundGut Microbiota is Altered in Patients with Alzheimer’s Disease
Zhuang, Z.-Q., Shen, L.-L., Li, W.-W., Fu, X., Zeng, F., Gui, L., Lü, Y., Cai, M., Zhu, C., Tan, Y.-L., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180176 · Cited by 885 · cited 1×
“when comparing 43 AD patients with age- and sex-matched controls: enriched Bacteroidetes and decreased Actinobacteria at the phylum level were paralleled by enhanced Ruminococcaceae, Enterococcaceae, and Lactobacillaceae, together with less Lanchnospiraceae, Bacteroidaceae, and Veillonellaceae at the family level [76].”
ResultBrain-Gut-Microbiota Axis in Alzheimer’s Disease
Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826
Interaction between BDNF and Serotonin: Role in Mood Disorders
Martinowich, K., & Lu, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301571 · Cited by 793
Prion-like mechanisms in neurodegenerative diseases
Frost, B., & Diamond, M. I. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2786 · Cited by 776
Mechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775 · cited 1×
“Intestinal dysbiosis is a condition of microbial imbalance caused by an overgrowth of “bad” bacteria inside the gut, associated with potential negative outcomes such as the incorrect production of essential metabolites or even the genesis of harmful metabolites [14,57].”
BackgroundBDNF: A key regulator for protein synthesis-dependent LTP and long-term memory?
Lu, Y., Christian, K., & Lu, B. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.08.018 · Cited by 768
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial
Martínez-Lapiscina, E. H., Clavero, P., Toledo, E., Estruch, R., Salas-Salvadó, J., San Julián, B., Sanchez-Tainta, A., Ros, E., Valls-Pedret, C., & Martinez-Gonzalez, M. Á. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304792 · Cited by 747
Heldt, S. A., Stanek, L., Chhatwal, J. P., & Ressler, K. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001957 · Cited by 684
Liu, P., Wu, L., Peng, G., Han, Y., Tang, R., Ge, J., Zhang, L., Jia, L., Yue, S., Zhou, K., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.05.008 · Cited by 669 · cited 3×
“…in the faeces and blood via 16S rRNA sequencing and MCI compared to controls 6= 11 genera in the feces and in the blood between AD/MCI and controls = Genera in the blood and feces between AD and MCI • Changes in gut microbiota as early diagnosis in AD Liu et al., 2019 [72] Brain Behav.”
BackgroundInfluentialNagpal, R., Neth, B. J., Wang, S., Craft, S., & Yadav, H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.032 · Cited by 653
Microbial genes, brain & behaviour – epigenetic regulation of the gut–brain axis
Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12109 · Cited by 637
Gut Microbiota and Obesity: A Role for Probiotics
Abenavoli, L., Scarpellini, E., Colica, C., Boccuto, L., Salehi, B., Sharifi-Rad, J., Aiello, V., Romano, B., De Lorenzo, A., Izzo, A. A., et al. (2019) · Nutrients · doi:10.3390/nu11112690 · Cited by 615
Kim, M.-S., Kim, Y., Choi, H., Kim, W., Park, S., Lee, D., Kim, D. K., Kim, H. J., Choi, H., Hyun, D.-W., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317431 · Cited by 614 · cited 3×
“…cocktails for 2 weeks by gavage and then FMT for 7 consecutive days by oral gavage ↑ Aβ plaques ↓ Astrocyte activation around Aβ plaques Kim et al., 2020 [10] Gut Mice (n = 16) WT mice ADLPAPT transgenic mouse model Fresh fecal matters for 16 weeks by oral gavage or for 4 weeks…”
BackgroundMethodInfluentialPoole, S., Singhrao, S. K., Kesavalu, L., Curtis, M. A., & Crean, S. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-121918 · Cited by 598
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
Garcia-Mantrana, I., Selma-Royo, M., Alcantara, C., & Collado, M. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00890 · Cited by 574
Wang, H.-X., & Wang, Y.-P. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.190667 · Cited by 546 · cited 1×
“In this communicating network, the brain affects gut movement, sensory, and secretion functions, and in turn the signals from the gut affect brain function [24].”
BackgroundFilippou, C. D., Tsioufis, C. P., Thomopoulos, C. G., Mihas, C. C., Dimitriadis, K. S., Sotiropoulou, L. I., Chrysochoou, C. A., Nihoyannopoulos, P. I., & Tousoulis, D. M. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa041 · Cited by 539
Sun, J., Xu, J., Ling, Y., Wang, F., Gong, T., Yang, C., Ye, S., Ye, K., Wei, D., Song, Z., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0525-3 · Cited by 532
The blood-brain barrier and immune function and dysfunction
Banks, W. A., & Erickson, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.031 · Cited by 523 · cited 1×
“Specifically, toll-like receptors (TLRs) and peptidoglycans (PGNs) mediate the immune response towards microbes by acting as sensors of microbial components [30,31].”
BackgroundHeck, A. L., & Handa, R. J. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0167-9 · Cited by 520 · cited 1×
“This interplay involves the central nervous system (CNS), the autonomic nervous system, the enteric nervous system (ENS), and the hypothalamus-pituitary-adrenal axis (HPA), and it has been reported to be implicated in a number of physiological and pathological processes such as satiety, food intake, glucose and fat me…”
BackgroundGut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516
The microbiome: a key regulator of stress and neuroinflammation
Rea, K., Dinan, T. G., & Cryan, J. F. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.03.001 · Cited by 508 · cited 1×
“• Through pro-inflammatory cytokines and chemokines [29].”
Alzheimer’s Disease – Why We Need Early Diagnosis
Rasmussen, J., & Langerman, H. (2019) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s228939 · Cited by 501 · cited 1×
“It is widely thought that an early diagnosis could be essential to act at the earliest disease stages, but effective and reproducible biomarkers are still far from clinical application [7,8].”
BackgroundLipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
Fecal microbiota transplantation: in perspective
Gupta, S., Allen-Vercoe, E., & Petrof, E. O. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15607414 · Cited by 481
Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease
Kesika, P., Suganthy, N., Sivamaruthi, B. S., & Chaiyasut, C. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118627 · Cited by 479 · cited 1×
“, have been shown to contribute to the development of AD pathology particularly by promoting Aβ oligomers and fibrils formation [38].”
BackgroundMild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota
Li, B., He, Y., Ma, J., Huang, P., Du, J., Cao, L., Wang, Y., Xiao, Q., Tang, H., & Chen, S. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.07.002 · Cited by 478 · cited 1×
“…WT controls Gut microbiota composition analysis ↑Wolbachia in AD flies compared to controls ↓Gut microbiota diversity in AD flies compared to controls • Wolbachia as a potential biomarker for AD • Stenotrophomonas negatively correlated with neurodegeneration Li et al., 2019 [113] Alzheimers Dement.”
BackgroundThe gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
Vogt, N. M., Romano, K. A., Darst, B. F., Engelman, C. D., Johnson, S. C., Carlsson, C. M., Asthana, S., Blennow, K., Zetterberg, H., Bendlin, B. B., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0451-2 · Cited by 471 · cited 11×
“Other suggestions might come from the evidence of a progressive shift from Faecalibacterium to Bifidobacterium genera in AD, thus offering the possibility to follow the ratio of butyrate/lactate producing genera as a disease marker of neurodegeneration [73].”
BackgroundInfluentialLucas, K., & Maes, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8425-7 · Cited by 466
Probiotics-host communication: Modulation of signaling pathways in the intestine
Thomas, C. M., & Versalovic, J. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.11712 · Cited by 457
Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 446
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445
Microbiota and metabolic diseases
Pascale, A., Marchesi, N., Marelli, C., Coppola, A., Luzi, L., Govoni, S., Giustina, A., & Gazzaruso, C. (2018) · Endocrine · doi:10.1007/s12020-018-1605-5 · Cited by 423 · cited 1×
“Intestinal dysbiosis is a condition of microbial imbalance caused by an overgrowth of “bad” bacteria inside the gut, associated with potential negative outcomes such as the incorrect production of essential metabolites or even the genesis of harmful metabolites [14,57].”
BackgroundSelf-citationMicrobiota-Gut-Brain Axis: New Therapeutic Opportunities
Long-Smith, C., O'Riordan, K. J., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023628 · Cited by 419
Influence of Mediterranean Diet on Human Gut Microbiota
Merra, G., Noce, A., Marrone, G., Cintoni, M., Tarsitano, M. G., Capacci, A., & De Lorenzo, A. (2020) · Nutrients · doi:10.3390/nu13010007 · Cited by 417
Influence of gut microbiota on neuropsychiatric disorders
Cenit, M. C., Sanz, Y., & Codoñer-Franch, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i30.5486 · Cited by 416
Haran, J. P., Bhattarai, S. K., Foley, S. E., Dutta, P., Ward, D. V., Bucci, V., & McCormick, B. A. (2019) · mBio · doi:10.1128/mbio.00632-19 · Cited by 412 · cited 2×
“Interestingly, these data have been correlated with low levels of expression of the P-glycoprotein, an essential molecule required for intestinal homeostasis, therefore indicating a clear nexus between microbiome dysregulation and intestinal inflammation [71].”
BackgroundKobayashi, Y., Sugahara, H., Shimada, K., Mitsuyama, E., Kuhara, T., Yasuoka, A., Kondo, T., Abe, K., & Xiao, J.-Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-13368-2 · Cited by 403
Zhao, Y., Jaber, V., & Lukiw, W. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00318 · Cited by 379
Alzheimer’s disease and gut microbiota
Hu, X., Wang, T., & Jin, F. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5083-9 · Cited by 371 · cited 1×
“The role of gut microbiota and GMBA in AD is of utmost importance [34].”
BackgroundRegulation of intestinal homeostasis and immunity with probiotic lactobacilli
van Baarlen, P., Wells, J. M., & Kleerebezem, M. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.01.005 · Cited by 368
Kashiwaya, Y., Bergman, C., Lee, J.-H., Wan, R., King, M. T., Mughal, M. R., Okun, E., Clarke, K., Mattson, M. P., & Veech, R. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.023 · Cited by 363
(1997) · Europe PMC (PubMed Central) · Cited by 354
Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition
Colombo, A. V., Sadler, R. K., Llovera, G., Singh, V., Roth, S., Heindl, S., Sebastian Monasor, L., Verhoeven, A., Peters, F., Parhizkar, S., et al. (2021) · eLife · doi:10.7554/elife.59826 · Cited by 354
The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology
Doifode, T., Giridharan, V. V., Generoso, J. S., Bhatti, G., Collodel, A., Schulz, P. E., Forlenza, O. V., & Barichello, T. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105314 · Cited by 347
Vanderpool, C., Yan, F., & Polk, B. D. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20525 · Cited by 340
Central Nervous System Regenerative Failure: Role of Oligodendrocytes, Astrocytes, and Microglia
Silver, J., Schwab, M. E., & Popovich, P. G. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020602 · Cited by 332 · cited 1×
“A local immune activation can, throughout different pathways, lead to an immune activation in different organs, including the brain [32].”
BackgroundVulnerability of the industrialized microbiota
Sonnenburg, J. L., & Sonnenburg, E. D. (2019) · Science · doi:10.1126/science.aaw9255 · Cited by 326
Browne, T. C., McQuillan, K., McManus, R. M., O’Reilly, J.-A., Mills, K. H. G., & Lynch, M. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200947 · Cited by 322
Wenzel, T. J., Gates, E. J., Ranger, A. L., & Klegeris, A. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103493 · Cited by 320
Hodson, R. (2018) · Nature · doi:10.1038/d41586-018-05717-6 · Cited by 320
Ketogenic Diet in Alzheimer’s Disease
Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163892 · Cited by 319
Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives
Choi, H. H., & Cho, Y.-S. (2016) · Clinical Endoscopy · doi:10.5946/ce.2015.117 · Cited by 318
Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer’s Mouse Model
Brandscheid, C., Schuck, F., Reinhardt, S., Schäfer, K.-H., Pietrzik, C. U., Grimm, M., Hartmann, T., Schwiertz, A., & Endres, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160926 · Cited by 318
16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer’s Post-Mortem Brain
Emery, D. C., Shoemark, D. K., Batstone, T. E., Waterfall, C. M., Coghill, J. A., Cerajewska, T. L., Davies, M., West, N. X., & Allen, S. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00195 · Cited by 317
Snowden, S. G., Ebshiana, A. A., Hye, A., An, Y., Pletnikova, O., O’Brien, R., Troncoso, J., Legido-Quigley, C., & Thambisetty, M. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002266 · Cited by 309
Morris, G., Berk, M., Carvalho, A., Caso, J. R., Sanz, Y., Walder, K., & Maes, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0004-2 · Cited by 307 · cited 1×
“Moreover, a decrease in butyrateproducing bacteria, as reported in AD, has been linked to T cell imbalance, epithelial barrier leakage (so called “leaky gut”), and increased bacterial translocation [80,87,88].”
BackgroundRole of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)
Włodarek, D. (2019) · Nutrients · doi:10.3390/nu11010169 · Cited by 301
Microbiota regulation of the mammalian gut-brain axis
Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice
Ma, D., Wang, A. C., Parikh, I., Green, S. J., Hoffman, J. D., Chlipala, G., Murphy, M. P., Sokola, B. S., Bauer, B., Hartz, A. M. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25190-5 · Cited by 299
Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298
Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes
Dodiya, H. B., Kuntz, T., Shaik, S. M., Baufeld, C., Leibowitz, J., Zhang, X., Gottel, N., Zhang, X., Butovsky, O., Gilbert, J. A., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182386 · Cited by 288
Shen, L., Liu, L., & Ji, H.-F. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160884 · Cited by 277 · cited 2×
“Whilst species of Prevotella and Helicobacter have been shown to be significantly different between APP/PS1 transgenic mice and controls, Actinobacteria and TM7 phylum seem to be more accurate in diagnosing AD when using the triple transgenic mouse model [106,107,109].”
BackgroundXie, Z., Wei, M., Morgan, T. E., Fabrizio, P., Han, D., Finch, C. E., & Longo, V. D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03484.2002 · Cited by 272
Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease
Taylor, M. K., Sullivan, D. K., Mahnken, J. D., Burns, J. M., & Swerdlow, R. H. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.11.002 · Cited by 272
Kim, Y.-K., & Shin, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915141036 · Cited by 271 · cited 1×
“Given this complex interplay, it is not surprising that the gut–brain axis, and therefore the gut microbiota as main component of this crosstalk, directly or indirectly affects neuropsychiatric illnesses [33].”
BackgroundBonfili, L., Cecarini, V., Cuccioloni, M., Angeletti, M., Berardi, S., Scarpona, S., Rossi, G., & Eleuteri, A. M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0973-4 · Cited by 268
Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors
Fuke, N., Nagata, N., Suganuma, H., & Ota, T. (2019) · Nutrients · doi:10.3390/nu11102277 · Cited by 268 · cited 1×
“Moreover, a decrease in butyrateproducing bacteria, as reported in AD, has been linked to T cell imbalance, epithelial barrier leakage (so called “leaky gut”), and increased bacterial translocation [80,87,88].”
BackgroundUłamek-Kozioł, M., Czuczwar, S. J., Januszewski, S., & Pluta, R. (2019) · Nutrients · doi:10.3390/nu11102510 · Cited by 266
Athari Nik Azm, S., Djazayeri, A., Safa, M., Azami, K., Ahmadvand, B., Sabbaghziarani, F., Sharifzadeh, M., & Vafa, M. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0648 · Cited by 262
Agahi, A., Hamidi, G. A., Daneshvar, R., Hamdieh, M., Soheili, M., Alinaghipour, A., Esmaeili Taba, S. M., & Salami, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00662 · Cited by 247
Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease
Ling, Z., Zhu, M., Yan, X., Cheng, Y., Shao, L., Liu, X., Jiang, R., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.634069 · Cited by 241 · cited 2×
“Ling et al., 2021 [73] Front.”
BackgroundLiu, Q., Xi, Y., Wang, Q., Liu, J., Li, P., Meng, X., Liu, K., Chen, W., Liu, X., & Liu, Z. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.04.005 · Cited by 241
Distrutti, E., O’Reilly, J.-A., McDonald, C., Cipriani, S., Renga, B., Lynch, M. A., & Fiorucci, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106503 · Cited by 237
Bacteriocin production by Bifidobacterium spp. A review
Martinez, F. A. C., Balciunas, E. M., Converti, A., Cotter, P. D., & de Souza Oliveira, R. P. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.01.010 · Cited by 233
Köhler, C., Maes, M., Slyepchenko, A., Berk, M., Solmi, M., Lanctôt, K., & Carvalho, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160907093807 · Cited by 233 · cited 1×
“Moreover, a decrease in butyrateproducing bacteria, as reported in AD, has been linked to T cell imbalance, epithelial barrier leakage (so called “leaky gut”), and increased bacterial translocation [80,87,88].”
BackgroundMancuso, C., & Santangelo, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.009 · Cited by 232 · cited 1×
“Extrinsic factors including diet, lifestyle, or also pro-inflammatory insults, along with intrinsic components including genetic polymorphism, immunity, metabolites, and hormones, profoundly affect the composition of the gut microflora, which in turn produces signaling molecules such as short chain fatty acids (SCFAs)…”
BackgroundKim, N., Jeon, S. H., Ju, I. G., Gee, M. S., Do, J., Oh, M. S., & Lee, J. K. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.09.002 · Cited by 231
Den, H., Dong, X., Chen, M., & Zou, Z. (2020) · Aging · doi:10.18632/aging.102810 · Cited by 230
Chen, D., Yang, X., Yang, J., Lai, G., Yong, T., Tang, X., Shuai, O., Zhou, G., Xie, Y., & Wu, Q. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00403 · Cited by 227
Wu, L., Han, Y., Zheng, Z., Peng, G., Liu, P., Yue, S., Zhu, S., Chen, J., Lv, H., Shao, L., et al. (2021) · Nutrients · doi:10.3390/nu13010228 · Cited by 227 · cited 1×
“…and healthy controls (n = 335) Cerebrospinal TMAO levels measurement ↑ TMAO in AD and MCI compared to controls • TMAO levels in the cerebrospinal fluid Wu et al., 2021 [115] Nutrients Humans: AD patients (n = 27), MCI patients (n = 22) and healthy controls (n = 28) LC/GC/MS metabolomics profiling…”
BackgroundSofi, F., Macchi, C., Abbate, R., Gensini, G. F., & Casini, A. (2013) · BioFactors · doi:10.1002/biof.1096 · Cited by 213
Goyal, D., Ali, S. A., & Singh, R. K. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110112 · Cited by 205
Hazan, S. (2020) · Journal of International Medical Research · doi:10.1177/0300060520925930 · Cited by 200
Maes, M., Mihaylova, I., & Leunis, J.-C. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.021 · Cited by 197
Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
Rahman, M. H., Akter, R., Bhattacharya, T., Abdel-Daim, M. M., Alkahtani, S., Arafah, M. W., Al-Johani, N. S., Alhoshani, N. M., Alkeraishan, N., Alhenaky, A., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619024 · Cited by 193
Shabbir, U., Arshad, M. S., Sameen, A., & Oh, D.-H. (2021) · Nutrients · doi:10.3390/nu13020690 · Cited by 191
Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?
Asti, A., & Gioglio, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131394 · Cited by 180
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease
Colciaghi, F., Marcello, E., Borroni, B., Zimmermann, M., Caltagirone, C., Cattabeni, F., Padovani, A., & Di Luca, M. (2004) · Neurology · doi:10.1212/01.wnl.0000106953.49802.9c · Cited by 178
Kahn, M. S., Kranjac, D., Alonzo, C. A., Haase, J. H., Cedillos, R. O., McLinden, K. A., Boehm, G. W., & Chumley, M. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.010 · Cited by 177 · cited 1×
“Even the injection of LPS in mice induces elevation of Aβ in the hippocampal area causing cognition defects, thus supporting the role of LPS in amyloid fibrillogenesis [40,41].”
Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice
Zhan, G., Yang, N., Li, S., Huang, N., Fang, X., Zhang, J., Zhu, B., Yang, L., Yang, C., & Luo, A. (2018) · Aging · doi:10.18632/aging.101464 · Cited by 176
Guo, M., Peng, J., Huang, X., Xiao, L., Huang, F., & Zuo, Z. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201040 · Cited by 176 · cited 1×
“However, in contrast with this evidence, lower Bacteroides, Lachnospira, and Ruminiclostridium and higher levels of Prevotella have been reported in another study [77].”
ResultThe Possibility of an Infectious Etiology of Alzheimer Disease
Ashraf, G. M., Tarasov, V. V., Makhmutovа, A., Chubarev, V. N., Avila-Rodriguez, M., Bachurin, S. O., & Aliev, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1388-y · Cited by 175 · cited 1×
“or traumatic events affecting the brain (traumatic brain injury) can interfere with central immune homeostasis and accelerate the progression of the disease [3].”
BackgroundManipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies
Shanahan, F., & Quigley, E. M. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.050 · Cited by 172
The effects of grape and red wine polyphenols on gut microbiota – A systematic review
Nash, V., Ranadheera, C. S., Georgousopoulou, E. N., Mellor, D. D., Panagiotakos, D. B., McKune, A. J., Kellett, J., & Naumovski, N. (2018) · Food Research International · doi:10.1016/j.foodres.2018.07.019 · Cited by 165
Lee, H.-J., Lee, K.-E., Kim, J.-K., & Kim, D.-H. (2019) · Scientific Reports · doi:10.1038/s41598-019-48342-7 · Cited by 164
Ketone bodies, stress response, and redox homeostasis
Rojas‐Morales, P., Pedraza‐Chaverrí, J., & Tapia, E. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101395 · Cited by 163
Ling, Z., Liu, X., Jia, X., Cheng, Y., Luo, Y., Yuan, L., Wang, Y., Zhao, C., Guo, S., Li, L., et al. (2014) · Scientific Reports · doi:10.1038/srep07485 · Cited by 158
Park, S.-H., Lee, J. H., Shin, J., Kim, J.-S., Cha, B., Lee, S., Kwon, K. S., Shin, Y. W., & Choi, S. H. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1957807 · Cited by 157
Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
Hammond, C. J., Hallock, L. R., Howanski, R. J., Appelt, D. M., Little, C. S., & Balin, B. J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-121 · Cited by 156
Rosenblum, W. I. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.085 · Cited by 154
Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease
Arbo, B. D., André-Miral, C., Nasre-Nasser, R. G., Schimith, L. E., Santos, M. G., Costa-Silva, D., Muccillo-Baisch, A. L., & Hort, M. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00103 · Cited by 154
Ketones block amyloid entry and improve cognition in an Alzheimer's model
Yin, J. X., Maalouf, M., Han, P., Zhao, M., Gao, M., Dharshaun, T., Ryan, C., Whitelegge, J., Wu, J., Eisenberg, D., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.018 · Cited by 151
Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders
Evrensel, A., & Ceylan, M. E. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.3.231 · Cited by 150
Biomarkers for Alzheimer’s Disease Early Diagnosis
Ausó, E., Gómez-Vicente, V., & Esquiva, G. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030114 · Cited by 149 · cited 1×
“It is widely thought that an early diagnosis could be essential to act at the earliest disease stages, but effective and reproducible biomarkers are still far from clinical application [7,8].”
BackgroundThe ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease
Broom, G. M., Shaw, I. C., & Rucklidge, J. J. (2019) · Nutrition · doi:10.1016/j.nut.2018.10.003 · Cited by 148
Chen, Y., Fang, L., Chen, S., Zhou, H., Fan, Y., Lin, L., Li, J., Xu, J., Chen, Y., Ma, Y., et al. (2020) · BioMed Research International · doi:10.1155/2020/8456596 · Cited by 146
Oleskin, A. V., & Shenderov, B. A. (2016) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v27.30971 · Cited by 145 · cited 1×
“Finally, the ability of some endobacteria to produce gaseotransmitter molecules, such as nitric oxide (NO), hydrogen (H2), ammonia (NH3), methane (CH4), and hydrogen sulfide (H2S) seems to be fundamental for the proper neuronal function, and its alteration participates to AD pathogenesis [96,97].”
BackgroundRelevance of gutmicrobiota in cognition, behaviour and Alzheimer’s disease
de J.R. De-Paula, V., Forlenza, A. S., & Forlenza, O. V. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.007 · Cited by 145
MIND diet and cognitive performance in older adults: a systematic review
Kheirouri, S., & Alizadeh, M. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1925220 · Cited by 143
Miklossy, J. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160451 · Cited by 140
Gaseotransmitters: New Frontiers for Translational Science
Szabo, C. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000721 · Cited by 139 · cited 1×
“Finally, the ability of some endobacteria to produce gaseotransmitter molecules, such as nitric oxide (NO), hydrogen (H2), ammonia (NH3), methane (CH4), and hydrogen sulfide (H2S) seems to be fundamental for the proper neuronal function, and its alteration participates to AD pathogenesis [96,97].”
BackgroundGut Metagenomics-Derived Genes as Potential Biomarkers of Parkinson’s Disease
Qian, Y., Yang, X., Xu, S., Huang, P., Li, B., Du, J., He, Y., Su, B., Xu, L.-M., Wang, L., et al. (2020) · Brain · doi:10.1093/brain/awaa201 · Cited by 139
Xu, M., Mo, X., Huang, H., Chen, X., Liu, H., Peng, Z., Chen, L., Rong, S., Yang, W., Xu, S., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.180 · Cited by 137
The link between altered cholesterol metabolism and Alzheimer's disease
Gamba, P., Testa, G., Sottero, B., Gargiulo, S., Poli, G., & Leonarduzzi, G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06513.x · Cited by 134
Fujii, Y., Nguyen, T. T. T., Fujimura, Y., Kameya, N., Nakamura, S., Arakawa, K., & Morita, H. (2019) · Bioscience, Biotechnology, and Biochemistry · doi:10.1080/09168451.2019.1644149 · Cited by 132
Cerovic, M., Forloni, G., & Balducci, C. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00284 · Cited by 128 · cited 1×
“Although the mechanisms underlying this interaction are not fully understood, targeting the microbiota might represent a new diagnostic and therapeutic strategy in AD and in other neurodegenerative diseases [23].”
BackgroundThe Current Status of the Ketogenic Diet in Psychiatry
Bostock, E. C. S., Kirkby, K. C., & Taylor, B. V. M. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00043 · Cited by 127
Knight, A., Bryan, J., Wilson, C., Hodgson, J., Davis, C., & Murphy, K. (2016) · Nutrients · doi:10.3390/nu8090579 · Cited by 122
Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut Microbiome
Hoffman, J. D., Parikh, I., Green, S. J., Chlipala, G., Mohney, R. P., Keaton, M., Bauer, B., Hartz, A. M. S., & Lin, A.-L. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00298 · Cited by 122
Sichetti, M., De Marco, S., Pagiotti, R., Traina, G., & Pietrella, D. (2018) · Nutrition · doi:10.1016/j.nut.2018.02.005 · Cited by 119
Immunomodulatory effects of probiotics: Can they be used to treat allergies and autoimmune diseases?
Dargahi, N., Johnson, J., Donkor, O., Vasiljevic, T., & Apostolopoulos, V. (2019) · Maturitas · doi:10.1016/j.maturitas.2018.11.002 · Cited by 119
Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
Tan, P., Li, X., Shen, J., & Feng, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.574533 · Cited by 118
Effect of the NU-AGE Diet on Cognitive Functioning in Older Adults: A Randomized Controlled Trial
Marseglia, A., Xu, W., Fratiglioni, L., Fabbri, C., Berendsen, A. A. M., Bialecka-Debek, A., Jennings, A., Gillings, R., Meunier, N., Caumon, E., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00349 · Cited by 117
Gao, Q., Wang, Y., Wang, X., Fu, S., Zhang, X., Wang, R.-T., & Zhang, X. (2019) · Aging · doi:10.18632/aging.102352 · Cited by 117
Maes, M. H. J., Twisk, F., Kubera, M., Ringel, K., Leunis, J., & Geffard, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.09.010 · Cited by 116
Production of Bacteriocin-Like Inhibitory Compounds by Human Fecal Bifidobacterium Strains
Collado, M. C., Hernández, M., & Sanz, Y. (2005) · Journal of Food Protection · doi:10.4315/0362-028x-68.5.1034 · Cited by 115
Ma, Q.-L., Teter, B., Ubeda, O. J., Morihara, T., Dhoot, D., Nyby, M. D., Tuck, M. L., Frautschy, S. A., & Cole, G. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3593-07.2007 · Cited by 115
Microbiota modulation as preventative and therapeutic approach in Alzheimer’s disease
Bonfili, L., Cecarini, V., Gogoi, O., Gong, C., Cuccioloni, M., Angeletti, M., Rossi, G., & Eleuteri, A. M. (2021) · The FEBS Journal · doi:10.1111/febs.15571 · Cited by 115
Zhang, X., Wang, Y., Liu, W., Wang, T., Wang, L., Hao, L., Ju, M., & Xiao, R. (2021) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab078 · Cited by 115
Boyajian, J. L., Ghebretatios, M., Schaly, S., Islam, P., & Prakash, S. (2021) · Nutrients · doi:10.3390/nu13124550 · Cited by 115
Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer’s Disease
Kountouras, J., Boziki, M., Gavalas, E., Zavos, C., Deretzi, G., Grigoriadis, N., Tsolaki, M., Chatzopoulos, D., Katsinelos, P., Tzilves, D., et al. (2009) · International Journal of Neuroscience · doi:10.1080/00207450902782083 · Cited by 113 · cited 1×
“Furthermore, a significant increase in the level of Helicobacter pylori-specific IgG antibodies, found in the cerebrospinal fluid and in the serum of AD patients, was reported [53].”
BackgroundSerum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers
Bernath, M. M., Bhattacharyya, S., Nho, K., Barupal, D. K., Fiehn, O., Baillie, R., Risacher, S. L., Arnold, M., Jacobson, T., Trojanowski, J. Q., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009436 · Cited by 113
Diet and Alzheimer's dementia – Nutritional approach to modulate inflammation
Szczechowiak, K., Diniz, B. S., & Leszek, J. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172743 · Cited by 112
FUNCTIONAL MECHANISMS OF PROBIOTICS
Kumar Bajaj, B., J.J. Claes, I., & Lebeer, S. (2015) · Journal of microbiology, biotechnology and food sciences · doi:10.15414/jmbfs.2015.4.4.321-327 · Cited by 111
Cole, G. M., & Frautschy, S. A. (2006) · Nutrition and Health · doi:10.1177/026010600601800307 · Cited by 110
Bacterial Lipodipeptide, Lipid 654, Is a Microbiome-Associated Biomarker for Multiple Sclerosis
Farrokhi, V., Nemati, R., Nichols, F. C., Yao, X., Anstadt, E., Fujiwara, M., Grady, J., Wakefield, D., Castro, W., Donaldson, J., et al. (2013) · Clinical & Translational Immunology · doi:10.1038/cti.2013.11 · Cited by 109
Mietelska-Porowska, A., & Wojda, U. (2017) · Journal of Immunology Research · doi:10.1155/2017/4626540 · Cited by 107 · cited 1×
“One of the major concerns in AD research is to find predictive, sensitive, non-invasive accurate, and accessible biomarkers for early disease diagnosis [98,99].”
BackgroundClinical Trials in Alzheimer’s Disease: A Hurdle in the Path of Remedy
Oxford, A. E., Stewart, E. S., & Rohn, T. T. (2020) · International Journal of Alzheimer's Disease · doi:10.1155/2020/5380346 · Cited by 107
Mullane, K., & Williams, M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113945 · Cited by 105 · cited 3×
“Although many studies focus on fluid biomarkers for early disease detection, we are still far from having found an effective and consistent assay to be used in the clinical practice [100].”
BackgroundMethodInfluentialGutierrez, L., Folch, A., Rojas, M., Cantero, J. L., Atienza, M., Folch, J., Camins, A., Ruiz, A., Papandreou, C., & Bulló, M. (2021) · Nutrients · doi:10.3390/nu13113728 · Cited by 105
Xin, Y., Diling, C., Jian, Y., Ting, L., Guoyan, H., Hualun, L., Xiaocui, T., Guoxiao, L., Ou, S., Chaoqun, Z., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00412 · Cited by 104
Cui, B., Su, D., Li, W., She, X., Zhang, M., Wang, R., & Zhai, Q. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1223-4 · Cited by 104
Park, S., Zhang, T., Wu, X., & Qiu, J. Y. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-87 · Cited by 102
LPS-induced neuroinflammatory effects do not recover with time
Hauss-Wegrzyniak, B., Vraniak, P. D., & Wenk, G. L. (2000) · NeuroReport · doi:10.1097/00001756-200006050-00032 · Cited by 99
Mechanisms of ketogenic diet action
Masino, S. A., & Rho, J. M. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02871.x · Cited by 99
Research Progress on Alzheimer's Disease and Resveratrol
Yan, Y., Yang, H., Xie, Y., Ding, Y., Kong, D., & Yu, H. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03007-0 · Cited by 98
O'Hagan, C., Li, J. V., Marchesi, J. R., Plummer, S., Garaiova, I., & Good, M. A. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.05.015 · Cited by 96
Collado, M. C., Gueimonde, M., Sanz, Y., & Salminen, S. (2006) · Journal of Food Protection · doi:10.4315/0362-028x-69.7.1675 · Cited by 93
The Gut-Brain Axis in Alzheimer’s Disease and Omega-3. A Critical Overview of Clinical Trials
La Rosa, F., Clerici, M., Ratto, D., Occhinegro, A., Licito, A., Romeo, M., Iorio, C. D., & Rossi, P. (2018) · Nutrients · doi:10.3390/nu10091267 · Cited by 93
Self-citationProbiotics and prebiotics: focus on psychiatric disorders – a systematic review
Barbosa, R. S. D., & Vieira-Coelho, M. A. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz080 · Cited by 93
Rainey-Smith, S. R., Gu, Y., Gardener, S. L., Doecke, J. D., Villemagne, V. L., Brown, B. M., Taddei, K., Laws, S. M., Sohrabi, H. R., Weinborn, M., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0293-5 · Cited by 90
The protective effects of polyphenols on Alzheimer's disease: A systematic review
Colizzi, C. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.09.002 · Cited by 90
Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment
Lucidi, L., Pettorruso, M., Vellante, F., Carlo, F. D., Ceci, F., Santovito, M. C., Muzio, I. D., Fornaro, M., Ventriglio, A., Tomasetti, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073723 · Cited by 89
Dimache, A.-M., Șalaru, D. L., Sascău, R. A., & Stătescu, C. (2021) · Nutrients · doi:10.3390/nu13062118 · Cited by 89
Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer’s Disease
Wu, Y., Lee, W.-F., Salamanca, E., Yao, W.-L., Su, J.-N., Wang, S.-Y., Hu, C., & Chang, W. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084211 · Cited by 88 · cited 1×
“…and healthy controls (n = 335) Cerebrospinal TMAO levels measurement ↑ TMAO in AD and MCI compared to controls • TMAO levels in the cerebrospinal fluid Wu et al., 2021 [115] Nutrients Humans: AD patients (n = 27), MCI patients (n = 22) and healthy controls (n = 28) LC/GC/MS metabolomics profiling…”
BackgroundWang, M., Cao, J., Gong, C., Amakye, W. K., Yao, M., & Ren, J. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.06.003 · Cited by 88
Liu, Y.-H., Gao, X., Na, M., Kris-Etherton, P. M., Mitchell, D. C., & Jensen, G. L. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200499 · Cited by 86
Gu, X., Zhou, J., Zhou, Y., Wang, H., Si, N., Ren, W., Zhao, W., Fan, X., Gao, W., Wei, X., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00779-7 · Cited by 81 · cited 3×
“In this respect, it would be interesting to investigate whether SCFAs, in combination with other fluid biomarkers, might prove effective in disease diagnosis and clinical monitoring, as some evidence already suggested [108].”
BackgroundInfluentialPlatelets and Alzheimer’s disease: Potential of APP as a biomarker
Evin, G. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i6.102 · Cited by 80
Tan, F. H. P., Liu, G., Lau, S.-Y. A., Jaafar, M. H., Park, Y.-H., Azzam, G., Li, Y., & Liong, M.-T. (2020) · Beneficial Microbes · doi:10.3920/bm2019.0086 · Cited by 79 · cited 1×
“…samples ↑ Proteobacteriaceae, Verrucomicrobiaceae, Bifidobacteriaceae, Erysipelotrichaceae and Prevotellaceae in APP/PS1 mice ↓ Bacteroidaceae and Rikenellaceae in APP/PS1 mice • Changes in gut microbiota composition precede plaque deposition: early biomarker Tan et al., 2020 [111] Benef.”
BackgroundLatest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
Milà-Alomà, M., Suárez-Calvet, M., & Molinuevo, J. L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419888819 · Cited by 78 · cited 1×
“One of the major concerns in AD research is to find predictive, sensitive, non-invasive accurate, and accessible biomarkers for early disease diagnosis [98,99].”
BackgroundLee, Y.-S., Lai, D.-M., Huang, H.-J., Lee-Chen, G.-J., Chang, C.-H., Hsieh-Li, H. M., & Lee, G.-C. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07327 · Cited by 77
Better diet quality relates to larger brain tissue volumes: The Rotterdam Study
Croll, P. H., Voortman, T., Ikram, M. A., Franco, O. H., Schoufour, J. D., Bos, D., & Vernooij, M. W. (2018) · Neurology · doi:10.1212/wnl.0000000000005691 · Cited by 76
Cited by
Communication of gut microbiota and brain via immune and neuroendocrine signaling
Kasarello, K., Cudnoch-Jedrzejewska, A., & Czarzasta, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1118529 · Cited by 247
“Moreover, numerous studies indicate a wellchosen diet as a quick way to modify the composition and metabolism of the gut microbiota, reduce inflammation, and help maintain eubiosis and proper dependencies in the gut-brain axis (Metta et al., 2022; Varesi et al., 2022).”
BackgroundResultUpdates in Alzheimer's disease: from basic research to diagnosis and therapies
Liu, E., Zhang, Y., & Wang, J.-Z. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 199
“The human gut harbors bacteria, viruses, and fungi [138].”
BackgroundAn Explainable AI Paradigm for Alzheimer’s Diagnosis Using Deep Transfer Learning
Mahmud, T., Barua, K., Habiba, S. U., Sharmen, N., Hossain, M. S., & Andersson, K. (2024) · Diagnostics · doi:10.3390/diagnostics14030345 · Cited by 167
“For feature extraction, by leveraging its ability to capture high-level features from input images, such as edges, textures, and shapes, we used EfficientNet as a feature extractor [1], where we realized a 6400 × 1280 feature matrix [33].”
MethodBlood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 139
“Though data are still inconclusive, gut bacteria family and genus shifts might represent promising tools as novel biomarkers for the diagnosis and progression of AD, and the restoration of gut microbiota balance a potential therapeutic approach [380].”
BackgroundSelf-citationBicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 147
“There is also some evidence that MCI and early-stage AD already show signs of pro-inflammatory bacteria increases, such as Escherichia/Shigella , in addition to increased inflammation [68].”
Metadata
- Authors
- Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., & Pascale, A.
- Affiliations
- University of Pavia (IT)
- University of Lancashire (GB)
- Université Libre de Bruxelles (BE)
- Policlinico San Matteo Fondazione (IT)
- Council for Nutritional and Environmental Medicine (NO)
- University of Verona (IT)
- Corresponding author
- Varesi, Angelica
- Ricevuti, Giovanni
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-02-05
- Volume
- 14
- Issue
- 3
- Pages
- 668
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8840394
- OpenAlex
- W4210475085
- Cited by
- 225
- References
- 248
- Citations by year
- 2026: 24 · 2025: 54 · 2024: 68 · 2023: 53 · 2022: 26
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CLOK (University of Central Lancashire) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IrInSubria (University of Insubria) (submittedVersion, other-oa)
- Funders
- Università degli Studi di Pavia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- gut microbiota, Alzheimer's disease, gut-brain axis, dysbiosis, neurodegeneration, microbiota-based therapy, prebiotics, probiotics, fecal microbiota transplantation, diet, early diagnosis, disease progression
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Alzheimer Disease, Humans, Prebiotics, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.